{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:18:55Z","timestamp":1788304735602,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-026-07921-4","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:34:02Z","timestamp":1782088442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Celecoxib modulates inflammatory and immunoregulatory gene expression in human monocyte-derived dendritic cells"],"prefix":"10.1186","volume":"19","author":[{"given":"Vida","family":"Hashemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Baghbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazila","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahya Zolfaghar","family":"Ghoshooni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"7921_CR1","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3389\/fimmu.2017.01514","volume":"8","author":"C Obregon","year":"2017","unstructured":"Obregon C, et al. Update on dendritic cell-induced immunological and clinical tolerance. Front Immunol. 2017;8:1514.","journal-title":"Front Immunol"},{"key":"7921_CR2","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3389\/fimmu.2019.02393","volume":"10","author":"J Fucikova","year":"2019","unstructured":"Fucikova J, et al. Induction of tolerance and immunity by dendritic cells: mechanisms and clinical applications. Front Immunol. 2019;10:2393.","journal-title":"Front Immunol"},{"key":"7921_CR3","doi-asserted-by":"publisher","first-page":"633436","DOI":"10.3389\/fimmu.2021.633436","volume":"12","author":"S Ness","year":"2021","unstructured":"Ness S, Lin S, Gordon JR. Regulatory dendritic cells, T cell tolerance, and dendritic cell therapy for immunologic disease. Front Immunol. 2021;12:633436.","journal-title":"Front Immunol"},{"key":"7921_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fimmu.2015.00569","volume":"6","author":"VK Raker","year":"2015","unstructured":"Raker VK, Domogalla MP, Steinbrink K. Tolerogenic dendritic cells for regulatory T cell induction in man. Front Immunol. 2015;6:569.","journal-title":"Front Immunol"},{"key":"7921_CR5","doi-asserted-by":"publisher","first-page":"1099811","DOI":"10.3389\/fonc.2023.1099811","volume":"13","author":"K Jin","year":"2023","unstructured":"Jin K, et al. Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells. Front Oncol. 2023;13:1099811.","journal-title":"Front Oncol"},{"issue":"2","key":"7921_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/biomedicines11020445","volume":"11","author":"A Kulesza","year":"2023","unstructured":"Kulesza A, Paczek L, Burdzinska A. The role of COX-2 and PGE2 in the regulation of immunomodulation and other functions of mesenchymal stromal cells. Biomedicines. 2023;11(2):445.","journal-title":"Biomedicines"},{"issue":"3","key":"7921_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/cmi.2013.1","volume":"10","author":"H Harizi","year":"2013","unstructured":"Harizi H. Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology. Cell Mol Immunol. 2013;10(3):213\u201321.","journal-title":"Cell Mol Immunol"},{"issue":"20","key":"7921_CR8","first-page":"5498","volume":"118","author":"N Obermajer","year":"2011","unstructured":"Obermajer N, et al. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood J Am Soc Hematol. 2011;118(20):5498\u2013505.","journal-title":"Blood J Am Soc Hematol"},{"key":"7921_CR9","unstructured":"Gualde N, Gualde N. Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. Cell Mol Immunol. 2006;3(4):271-7."},{"issue":"2","key":"7921_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/intimm\/dxm134","volume":"20","author":"T Bryn","year":"2008","unstructured":"Bryn T, et al. LPS-activated monocytes suppress T-cell immune responses and induce FOXP3\u2009+\u2009T cells through a COX-2\u2013PGE2-dependent mechanism. Int Immunol. 2008;20(2):235\u201345.","journal-title":"Int Immunol"},{"issue":"1","key":"7921_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/CJI.0b013e31818ac2f7","volume":"32","author":"SY Lee","year":"2009","unstructured":"Lee SY, et al. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells. J Immunother. 2009;32(1):22\u20138.","journal-title":"J Immunother"},{"issue":"1","key":"7921_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4049\/jimmunol.163.1.111","volume":"163","author":"MA Iniguez","year":"1999","unstructured":"Iniguez MA, Punz\u00f3n C, Fresno M. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. J Immunol. 1999;163(1):111\u20139.","journal-title":"J Immunol"},{"key":"7921_CR13","doi-asserted-by":"crossref","unstructured":"Devi KSP, Anandasabapathy N. The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues. Semin Immunopathol. 2017;39:137\u201352.","DOI":"10.1007\/s00281-016-0602-0"},{"key":"7921_CR14","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3389\/fimmu.2017.01764","volume":"8","author":"MP Domogalla","year":"2017","unstructured":"Domogalla MP, et al. Tolerance through education: how tolerogenic dendritic cells shape immunity. Front Immunol. 2017;8:1764.","journal-title":"Front Immunol"},{"issue":"8","key":"7921_CR15","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.4049\/jimmunol.165.8.4298","volume":"165","author":"DS Whittaker","year":"2000","unstructured":"Whittaker DS, et al. Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production. J Immunol. 2000;165(8):4298\u2013304.","journal-title":"J Immunol"},{"issue":"1","key":"7921_CR16","doi-asserted-by":"publisher","first-page":"e151312","DOI":"10.5812\/ijpr-151312","volume":"23","author":"M Tajdari","year":"2024","unstructured":"Tajdari M, et al. Dual COX-2\/TNF-\u03b1 inhibitors as promising anti-inflammatory and cancer chemopreventive agents: A review. Iran J Pharm research: IJPR. 2024;23(1):e151312.","journal-title":"Iran J Pharm research: IJPR"},{"key":"7921_CR17","doi-asserted-by":"crossref","unstructured":"Sarkar OS, et al. Tumor-educated monocytes suppress T cells via adenosine and depletion of adenosine in the tumor microenvironment with adenosine deaminase enzyme promotes response to immunotherapy. bioRxiv, 2022:2022\u201306.","DOI":"10.1101\/2022.06.22.497260"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-026-07921-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07921-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07921-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:09:37Z","timestamp":1788304177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13104-026-07921-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7921"],"URL":"https:\/\/doi.org\/10.1186\/s13104-026-07921-4","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Maragheh University of Medical Sciences (MRGUMS) (Approval No. IR.MARAGHEHPHC.REC.1402.013). Written informed consent was obtained from all participants. All procedures involving human participants were conducted in accordance with the Declaration of Helsinki and its subsequent amendments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"342"}}